CL
Bearish signal
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Supports a bullish reading. 2 purchase disclosures year to date
- Financial indicators Unavailable or mixed. Current ratio 1.00 · operating margin 21% — readings disagree
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. No stored price series
VENTE TOTALE: 326 212 titres (~30 087 974,53 $ US)
- Insiders
- CAHILL JOHN TWallace Noel R.
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$30,087,975
Avg sell (VWAP, 90d window) $92.23 vs last close —
- Last activity
- 2026-08-06
- Last synced
-
2026-08-12 09:47:22
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-06 | CAHILL JOHN T | Sell | 4,170 | $93.37 | $389,358 | Form 4 |
| 2026-08-05 | Wallace Noel R. | Sell | 161,021 | $92.52 | $14,897,904 | Form 4 |
| 2026-08-04 | Wallace Noel R. | Sell | 161,021 | $91.92 | $14,800,712 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bearish signalScored 2026-08-26
CL presents a deeply unfavorable risk/reward profile: a weak liquidity score (45) combined with extreme financial leverage (ratio >300) and a current ratio below 1.0 signal meaningful balance sheet fragility despite…
The first sentence of the analysis written for CL on 2026-08-26 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 60.1% | 60.2% | 57.8% | 56.5% | 59.1% | |
| Ebit Margin | 16.3% | 21.1% | 18.9% | 15.7% | 18.4% | |
| Ebitda Margin | 19.4% | 24.1% | 21.8% | 18.8% | 21.6% | |
| Operating Profit Margin | 21.3% | 21.8% | 21.2% | 20.0% | 22.3% | |
| Pretax Profit Margin | 15.0% | 19.7% | 17.4% | 14.8% | 17.7% | |
| Continuous Operations Profit Margin | 11.1% | 15.2% | 12.6% | 10.9% | 13.4% | |
| Net Profit Margin | 10.5% | 14.4% | 11.8% | 9.9% | 12.4% | |
| Bottom Line Profit Margin | 10.5% | 14.4% | 11.8% | 9.9% | 12.4% | |
| Current Ratio | 0.995 | 0.923 | 1.113 | 1.277 | 1.085 | |
| Quick Ratio | 0.641 | 0.578 | 0.706 | 0.759 | 0.668 | |
| Solvency Ratio | 0.173 | 0.225 | 0.186 | 0.156 | 0.193 | |
| Cash Ratio | 0.225 | 0.190 | 0.204 | 0.194 | 0.205 | |
| Price To Earnings Ratio | 29.932 | 25.754 | 28.673 | 36.991 | 33.336 | |
| Price To Earnings Growth Ratio | -1.187 | 0.955 | 0.940 | -2.202 | -1.780 | |
| Forward Price To Earnings Growth Ratio | -1.187 | 0.955 | 0.940 | -2.202 | -1.780 | |
| Price To Earnings Diluted Ratio | 30.046 | 25.900 | 28.776 | 36.991 | 33.467 | |
| Price To Earnings Diluted Growth Ratio | -1.198 | 0.970 | 0.958 | -2.246 | -1.781 | |
| Price To Book Ratio | 1,183.398 | 350.647 | 108.296 | 164.339 | 118.411 | |
| Price To Sales Ratio | 3.135 | 3.698 | 3.390 | 3.668 | 4.139 | |
| Price To Free Cash Flow Ratio | 17.585 | 20.964 | 21.695 | 35.430 | 26.147 | |
| Price To Operating Cash Flow Ratio | 15.222 | 18.100 | 17.611 | 25.782 | 21.688 | |
| Debt To Assets Ratio | 0.489 | 0.530 | 0.553 | 0.589 | 0.521 | |
| Debt To Equity Ratio | 147.926 | 40.151 | 14.883 | 23.120 | 12.862 | |
| Debt To Capital Ratio | 0.993 | 0.976 | 0.937 | 0.959 | 0.928 | |
| Long Term Debt To Capital Ratio | 0.993 | 0.972 | 0.931 | 0.956 | 0.922 | |
| Financial Leverage Ratio | 302.407 | 75.689 | 26.918 | 39.229 | 24.696 | |
| Working Capital Turnover Ratio | -86.917 | 418.771 | 23.627 | 24.697 | 124.436 | |
| Operating Cash Flow Ratio | 0.732 | 0.713 | 0.790 | 0.638 | 0.821 | |
| Operating Cash Flow Sales Ratio | 0.206 | 0.204 | 0.192 | 0.142 | 0.191 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.866 | 0.863 | 0.812 | 0.728 | 0.829 | |
| Debt Service Coverage Ratio | 11.828 | 4.145 | 5.363 | 13.953 | 17.923 | |
| Interest Coverage Ratio | 16.285 | 15.010 | 14.394 | 21.467 | 33.214 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 6.223 | 11.348 | 102.240 | 65.196 | |
| Operating Cash Flow Coverage Ratio | 0.526 | 0.482 | 0.413 | 0.276 | 0.424 | |
| Capital Expenditure Coverage Ratio | 7.443 | 7.321 | 5.312 | 3.672 | 5.864 | |
| Dividend Paid And Capex Coverage Ratio | 1.759 | 1.748 | 1.526 | 1.071 | 1.480 | |
| Dividend Payout Ratio | 0.855 | 0.619 | 0.760 | 0.947 | 0.775 | |
| Enterprise Value Multiple | 17.847 | 16.846 | 17.440 | 22.063 | 21.041 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 60.1% | ▼-0.1% | ▲1.4% |
| Ebit Margin | 16.3% | ▼-4.8% | ▼-1.8% |
| Ebitda Margin | 19.4% | ▼-4.7% | ▼-1.7% |
| Operating Profit Margin | 21.3% | ▼-0.5% | ▲0.0% |
| Pretax Profit Margin | 15.0% | ▼-4.7% | ▼-1.9% |
| Continuous Operations Profit Margin | 11.1% | ▼-4.1% | ▼-1.6% |
| Net Profit Margin | 10.5% | ▼-3.9% | ▼-1.3% |
| Bottom Line Profit Margin | 10.5% | ▼-3.9% | ▼-1.3% |
| Current Ratio | 0.995 | ▲0.072 | ▼-0.084 |
| Quick Ratio | 0.641 | ▲0.063 | ▼-0.029 |
| Solvency Ratio | 0.173 | ▼-0.052 | ▼-0.014 |
| Cash Ratio | 0.225 | ▲0.034 | ▲0.021 |
| Price To Earnings Ratio | 29.932 | ▲4.178 | ▼-1.005 |
| Price To Earnings Growth Ratio | -1.187 | ▼-2.142 | ▼-0.532 |
| Forward Price To Earnings Growth Ratio | -1.187 | ▼-2.142 | ▼-0.532 |
| Price To Earnings Diluted Ratio | 30.046 | ▲4.145 | ▼-0.990 |
| Price To Earnings Diluted Growth Ratio | -1.198 | ▼-2.168 | ▼-0.539 |
| Price To Book Ratio | 1183.398 | ▲832.751 | ▲798.380 |
| Price To Sales Ratio | 3.135 | ▼-0.563 | ▼-0.471 |
| Price To Free Cash Flow Ratio | 17.585 | ▼-3.379 | ▼-6.779 |
| Price To Operating Cash Flow Ratio | 15.222 | ▼-2.878 | ▼-4.458 |
| Debt To Assets Ratio | 0.489 | ▼-0.041 | ▼-0.047 |
| Debt To Equity Ratio | 147.926 | ▲107.775 | ▲100.138 |
| Debt To Capital Ratio | 0.993 | ▲0.018 | ▲0.035 |
| Long Term Debt To Capital Ratio | 0.993 | ▲0.021 | ▲0.038 |
| Financial Leverage Ratio | 302.407 | ▲226.719 | ▲208.619 |
| Working Capital Turnover Ratio | -86.917 | ▼-505.688 | ▼-187.840 |
| Operating Cash Flow Ratio | 0.732 | ▲0.019 | ▼-0.007 |
| Operating Cash Flow Sales Ratio | 0.206 | ▲0.002 | ▲0.019 |
| Free Cash Flow Operating Cash Flow Ratio | 0.866 | ▲0.002 | ▲0.046 |
| Debt Service Coverage Ratio | 11.828 | ▲7.683 | ▲1.185 |
| Interest Coverage Ratio | 16.285 | ▲1.274 | ▼-3.789 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | ▼-6.223 | ▼-37.002 |
| Operating Cash Flow Coverage Ratio | 0.525 | ▲0.043 | ▲0.101 |
| Capital Expenditure Coverage Ratio | 7.443 | ▲0.122 | ▲1.521 |
| Dividend Paid And Capex Coverage Ratio | 1.759 | ▲0.011 | ▲0.242 |
| Dividend Payout Ratio | 0.855 | ▲0.236 | ▲0.064 |
| Enterprise Value Multiple | 17.847 | ▲1.001 | ▼-1.200 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $63.90B | $74.34B | $65.95B | $65.90B | $72.11B | |
| Enterprise value | $70.60B | $81.75B | $74.05B | $74.40B | $79.11B | |
| EV / Sales | 3.46x | 4.07x | 3.81x | 4.14x | 4.54x | |
| EV / Op. cash flow | 16.82x | 19.91x | 19.77x | 29.11x | 23.79x | |
| EV / Free cash flow | 19.43x | 23.05x | 24.36x | 40.00x | 28.68x | |
| EV / EBITDA | 17.85x | 16.85x | 17.44x | 22.06x | 21.04x | |
| Net debt / EBITDA | 1.69x | 1.53x | 1.91x | 2.52x | 1.86x | |
| Current ratio | 0.99x | 0.92x | 1.11x | 1.28x | 1.08x | |
| Income quality | 1.97x | 1.35x | 1.52x | 1.30x | 1.42x | |
| Graham number | $2 | $5 | $7 | $5 | $6 | |
| Graham net-net | -$15 | -$15 | -$15 | -$14 | -$14 | |
| Tax burden | 69.7% | 73.0% | 67.8% | 67.1% | 70.2% | |
| Interest burden | 92.0% | 93.1% | 92.2% | 94.1% | 96.3% | |
| Working capital | -$27.0M | -$442.0M | $538.0M | $1.11B | $346.0M | |
| Invested capital | $9.29B | $9.01B | $10.42B | $10.69B | $9.82B | |
| Return on assets | 13.1% | 18.0% | 14.0% | 11.3% | 14.4% | |
| Operating ROA | 26.9% | 27.0% | 25.7% | 23.3% | 25.1% | |
| Return on tangible assets | 18.3% | 26.2% | 20.7% | 17.1% | 23.3% | |
| Return on equity | 3948.1% | 1362.7% | 377.7% | 445.1% | 355.7% | |
| Return on invested capital | 30.3% | 30.6% | 24.8% | 22.4% | 26.3% | |
| Return on capital employed | 41.0% | 42.6% | 35.5% | 30.6% | 35.4% | |
| Earnings yield | 3.3% | 3.9% | 3.5% | 2.7% | 3.0% | |
| Free cash flow yield | 5.7% | 4.8% | 4.6% | 2.8% | 3.8% | |
| Capex / Op. cash flow | 13.4% | 13.7% | 18.8% | 27.2% | 17.1% | |
| Capex / Depreciation | 89.5% | 92.7% | 124.3% | 127.7% | 102.0% | |
| Capex / Sales | 2.8% | 2.8% | 3.6% | 3.9% | 3.3% | |
| SG&A / Sales | 38.8% | 38.9% | 34.8% | 34.8% | 35.0% | |
| R&D / Sales | 0.0% | 1.8% | 1.8% | 1.8% | 1.8% | |
| Stock comp / Sales | 0.0% | 0.7% | 0.6% | 0.7% | 0.8% | |
| Intangibles / Total assets | 28.5% | 31.3% | 32.3% | 33.5% | 38.2% | |
| Days sales outstanding | 30d | 28d | 30d | 31d | 27d | |
| Days payables outstanding | 0d | 82d | 76d | 72d | 76d | |
| Operating cycle | 121d | 118d | 116d | 127d | 114d | |
| Cash conversion cycle | 121d | 36d | 40d | 55d | 38d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-14.0%EV / Sales ▼-14.8%EV / EBITDA ▲+5.9%EV / Op. cash flow ▼-3.087Earnings yield ▼-0.006Graham number ▼-2.550
Profitability
Return on equity ▲+25.854Return on assets ▼-0.049Return on invested capital ▼-0.002Return on capital employed ▼-0.016Operating ROA ▼-0.002Income quality ▲+0.622Tax burden ▼-0.033
Efficiency
Days sales outstanding ▲+2.377Days payables outstanding ▼-82.405Operating cycle ▲+2.880Cash conversion cycle ▲+85.284Capex / Sales -0.000R&D / Sales ▼-0.018
Balance-sheet strength
Current ratio ▲+0.072Net debt / EBITDA ▲+0.166Working capital ▲+415000000.000Invested capital ▲+283000000.000Intangibles / Total assets ▼-0.028
Change over 5 years
Valuation
Market cap ▼-11.4%EV / Sales ▼-23.7%EV / EBITDA ▼-15.2%EV / Op. cash flow ▼-6.975Earnings yield ▲+0.003Graham number ▼-4.457
Profitability
Return on equity ▲+35.925Return on assets ▼-0.013Return on invested capital ▲+0.040Return on capital employed ▲+0.057Operating ROA ▲+0.018Income quality ▲+0.547Tax burden ▼-0.005
Efficiency
Days sales outstanding ▲+2.821Days payables outstanding ▼-75.734Operating cycle ▲+7.396Cash conversion cycle ▲+83.131Capex / Sales ▼-0.005R&D / Sales ▼-0.018
Balance-sheet strength
Current ratio ▼-0.090Net debt / EBITDA ▼-0.168Working capital ▼-373000000.000Invested capital ▼-531000000.000Intangibles / Total assets ▼-0.097
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
| Date | Member | Side | Amount range | Filing |
|---|---|---|---|---|
| 2025-04-08 | John Boozman | Buy | $1,001 - $15,000 | Filing |
| 2025-09-23 | Julie Johnson | Buy | $1,001 - $15,000 | Filing |
| 2025-09-23 | Julie Johnson | Buy | $1,001 - $15,000 | Filing |
| 2025-09-22 | Julie Johnson | Buy | $1,001 - $15,000 | Filing |
| 2026-06-02 | Ro Khanna | Buy | $1,001 - $15,000 | Filing |
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-06-02 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-01-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-01-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-10-07 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-10-06 | Rick Larsen | Sale | $1,001 - $15,000 |
| 2025-09-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-09-25 | Julie Johnson | Sale | $1,001 - $15,000 |
| 2025-09-23 | Julie Johnson | Sale | $1,001 - $15,000 |
| 2025-09-23 | Julie Johnson | Purchase | $1,001 - $15,000 |
| 2025-09-11 | Lisa McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-09-10 | Tim Moore | Sale | $1,001 - $15,000 |
| 2025-09-05 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-08-26 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-08-13 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2025-07-24 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-07-11 | Ritchie Torres | Sale (Full) | $1,001 - $15,000 |
| 2025-07-08 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-07-08 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-07-08 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-06-24 | Lisa McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-06-17 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2024-01-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-01-09 | Rick Larsen | Purchase | $1,001 - $15,000 |
| 2023-10-31 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-10-02 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-09-06 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2023-08-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-08-25 | Jeff Duncan | Sale (Full) | $1,001 - $15,000 |
| 2023-08-25 | Jeff Duncan | Sale Full | $1,001 - $15,000 |
| 2023-08-25 | Jeff Duncan | Sale Full | $1,001 - $15,000 |
| 2023-06-26 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-05-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-05-23 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-04-10 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-03-24 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-02-10 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2022-12-06 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-11-02 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-09-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-09-07 | Lois Frankel | Sale (Partial) | $1,001 - $15,000 |
| 2022-09-06 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-08-10 | Lois Frankel | Sale (Partial) | $1,001 - $15,000 |
| 2022-08-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-07-21 | Lois Frankel | Sale (Partial) | $1,001 - $15,000 |
| 2022-06-17 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-06-16 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2022-05-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-05-20 | Diana Harshbarger | Sale | $1,001 - $15,000 |
| 2022-05-20 | Diana Harshbarger | Sale | $1,001 - $15,000 |
| 2022-05-20 | Diana Harshbarger | Sale | $1,001 - $15,000 |
| 2022-05-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-05-05 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-04-21 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-04-11 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2021-04-07 | Lois Frankel | Purchase | $1,001 - $15,000 |
| 2021-02-10 | Lois Frankel | Purchase | $1,001 - $15,000 |
| 2021-01-28 | Lois Frankel | Purchase | $1,001 - $15,000 |
| 2020-12-30 | Sale (Full) | $1,001 - $15,000 | |
| 2020-04-29 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2020-03-23 | Zoe Lofgren | Sale (Full) | $1,001 - $15,000 |
| 2020-03-18 | Gilbert Cisneros | Sale (Partial) | $1,001 - $15,000 |
| 2020-02-20 | Mikie Sherrill | Sale (Full) | $1,001 - $15,000 |
| 2020-01-15 | Mikie Sherrill | Purchase | $1,001 - $15,000 |
| 2019-12-12 | Mikie Sherrill | Sale (Full) | $1,001 - $15,000 |
| 2019-12-06 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2019-10-15 | Kevin Hern | Purchase | $1,001 - $15,000 |
| 2019-08-07 | Kevin Hern | Purchase | $15,001 - $50,000 |
| 2019-05-23 | Donna Shalala | Sale (Full) | $1,001 - $15,000 |
| 2019-04-30 | Tom Malinowski | Sale (Partial) | $1,001 - $15,000 |
| 2019-02-05 | Donna Shalala | Sale (Partial) | $1,001 - $15,000 |
| 2019-01-29 | Tom Malinowski | Sale (Partial) | $1,001 - $15,000 |
Recent news
- 2026-08-09 What to Know About Colgate-Palmolive Director John Cahill Selling 4,170 Shares for $389,353 Cahill executed a sale of 4,170 shares on Aug. 6, 2026, realizing ~$389,353 in transaction value. The disposition reduced his total equity holdings by 6%, including shares acquired via option exercise, and 13% of his direct ownership.
- 2026-08-05 Colgate-Palmolive: The Reasons I Am Still Not A Buyer After The Q2 Results Colgate-Palmolive Company remains rated Hold due to valuation concerns, tepid organic growth, and persistent North American weakness. Q2 net sales rose 4.9%, but organic growth lagged at 2.4%, below both inflation and CL''s long-term target. Dividend and buyback returns are sustainable, but market pricing implies aggressive long-term growth assumptions not fully supported by fundamentals.
- 2026-07-31 Should Passive Income Investors Buy Colgate Palmolive Stock? Dividend stock investors have an excellent choice with this company.
- 2026-07-31 Colgate-Palmolive Co (CL) (Q2 2026) Earnings Call Highlights: Strong Organic Growth and Margin Expansion Amid US Challenges Organic Sales Growth: Organic sales growth was reported in four of five divisions and three of four categories.Emerging Markets Sales: Sales in emerging markets
- 2026-07-31 Colgate Q2 Earnings Beat Estimates on Strong Margins, Sales Rise 4.9% CL''s Q2 earnings beat as organic sales, productivity and margin gains offset higher brand investment, while Latin America led regional growth.
- 2026-07-31 Colgate-Palmolive Q2 Earnings Call Highlights Colgate-Palmolive NYSE: CL said its second-quarter 2026 results reflected broad-based organic sales growth, gross-margin expansion and higher advertising spending, while executives outlined steps to improve performance in North America amid softer category trends and elevated competition.
- 2026-07-31 Colgate-Palmolive Company (CL) Q2 2026 Earnings Call Transcript Colgate-Palmolive Company (CL) Q2 2026 Earnings Call Transcript
- 2026-07-31 Pre-Market Trading Up in Final Session of the Week Despite some mid-week turbulence, we''re trading fairly even with where we were as of mid-day Monday.
- 2026-07-31 Colgate-Palmolive: Steady Globally, Weak Domestically Colgate-Palmolive Company reported stable overall Q2 results. Organic revenues grew moderately, and margins stayed good. Growth varies by market. CL''s advertising investments are yielding results in Latin America and Asia Pacific, but competitive pressure is weakening results in North America. I estimate CL stock to have a fair value of $92.4.
- 2026-07-31 Colgate-Palmolive (CL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates Although the revenue and EPS for Colgate-Palmolive (CL) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.